Stock Taper
Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.

Overall rating: C+
| PEER | PRICE | |
|---|---|---|
KOYN | $10.24 | COMPARE |
EURK | $11.60 | COMPARE |
CPBI | $20.98 | COMPARE |
UYSC | $10.88 | COMPARE |
ORIQU | $10.38 | COMPARE |
RIBBU | $11.00 | COMPARE |
RIBB | $10.86 | COMPARE |